EUVIMEDScopri EUVIMED
Crossref

Changes in Insulin Secretion and Glucose Metabolism Induced by Dexamethasone in Lean and Obese Females

Christine Besse, Nathalie Nicod, Luc Tappy

Obesity Research · 2005-02 · 13 (2) · 306-311

DOI: 10.1038/oby.2005.41 ↗

At a glance

Journal article in Obesity Research, published online on 2012-09-06. Written by Christine Besse and 2 co-authors. Institution: Department of Physiology, University of Lausanne, Switzerland. Cited 32 times so far (Crossref); 14 references.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Objective

In healthy lean individuals, changes in insulin sensitivity occurring as a consequence of a 2‐day dexamethasone administration are compensated for by changes in insulin secretion, allowing glucose homeostasis to be maintained. This study evaluated the changes in glucose metabolism and insulin secretion induced by short‐term dexamethasone administration in obese women. Research Methods and Procedures : Eleven obese women with normal glucose tolerance were studied on two occasions, without and after 2 days of low‐dose dexamethasone administration. A two‐step hyperglycemic clamp (7.5 and 10 mM glucose) with 6, 6 2 H 2 glucose was used to assess insulin secretion and whole body glucose metabolism. Results were compared with those obtained in a group of eight lean women.

Results

Without dexamethasone, obese women had higher plasma insulin concentrations in the fasting state, during the first phase of insulin secretion, and at the two hyperglycemic plateaus. However, they had normal whole body glucose metabolism compared with lean women, indicating adequate compensation. After dexamethasone, obese women had a 66% to 92% increase in plasma insulin concentrations but a 15.4% decrease in whole body glucose disposal. This contrasted with lean women, who had a 91% to 113% increase in plasma insulin concentrations, with no change in whole body glucose disposal.

Discussion

Dexamethasone administration led to a significant reduction in whole body glucose disposal at fixed glycemia in obese but not lean women. This indicates that obese women are unable to increase their insulin secretion appropriately.

Subjects

MeSH terms (MEDLINE)

AdultBlood GlucoseDeuteriumDexamethasoneFemaleGlucoseGlucose Clamp TechniqueHumansHydrocortisoneInsulinInsulin SecretionLipid PeroxidationObesityOxidation-Reduction

Substances

Blood GlucoseInsulinDexamethasoneDeuteriumGlucoseHydrocortisone

Authors and institutions

  • Department of Physiology, University of Lausanne, Switzerland.

Cite

APA

Besse, C., Nicod, N., & Tappy, L. (2005). Changes in Insulin Secretion and Glucose Metabolism Induced by Dexamethasone in Lean and Obese Females. Obesity Research, 13(2), 306-311. https://doi.org/10.1038/oby.2005.41

Vancouver

Besse C, Nicod N, Tappy L. Changes in Insulin Secretion and Glucose Metabolism Induced by Dexamethasone in Lean and Obese Females. Obesity Research. 2005;13(2):306-311. doi:10.1038/oby.2005.41

BibTeX
@article{Besse2005,
  author = {Besse, Christine and Nicod, Nathalie and Tappy, Luc},
  title = {Changes in Insulin Secretion and Glucose Metabolism Induced by Dexamethasone in Lean and Obese Females},
  journal = {Obesity Research},
  year = {2005},
  volume = {13},
  number = {2},
  pages = {306--311},
  doi = {10.1038/oby.2005.41}
}
Start for free →